Back to search
Impaired Left Ventricular Ejection Fraction
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Impaired Left Ventricular Ejection Fraction trials may be worth asking aboutClinical trial pipeline · Data from ClinicalTrials.gov
See which Impaired Left Ventricular Ejection Fraction trials may be worth asking aboutNorth America
Europe
Asia-Pacific
Rest of World
Trials may have sites in multiple countries. Filtering shows any trial with at least one site in the selected country.
Evidence for the usefulness of the defibrillator in cases of preserved left ventricular ejection fraction and well-tolerated ventricular tachycardia (without ca…
Heart failure with preserved ejection (HFpEF) disproportionately affects Veterans and is the number one reason for hospital discharge in the VA Health Care Syst…
Previous studies have shown that patients with heart failure with reduced pumping function and preserved kidney function experience improved symptoms, longer su…
Although advances in treatment and patient management have considerably improved post-infarction prognosis, the risk of sudden cardiac death remains a major con…
The ISCHEMIA-HF trial will randomize participants with multivessel coronary artery disease (CAD) with ejection fraction (EF) ≤40% in a 1:2:2 fashion to guidelin…